Healthcare provider profile · identity verified

Victoria A Mccarthy, M.D.

Family Practice · FORT COLLINS, CO · NPI 1487603676

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	444	110
Atorvastatin Calcium	Atorvastatin Calcium	316	84
Lisinopril	Lisinopril	226	60
Rosuvastatin Calcium	Rosuvastatin Calcium	199	56
Losartan Potassium	Losartan Potassium	181	50
Amlodipine Besylate	Amlodipine Besylate	173	47
Gabapentin	Gabapentin	173	44
Hydrochlorothiazide	Hydrochlorothiazide	140	41
Metformin Hcl	Metformin Hcl	137	34
Trazodone Hcl	Trazodone Hcl	136	39
Omeprazole	Omeprazole	135	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	131	22
Eliquis	Apixaban	126	20
Tramadol Hcl	Tramadol Hcl	119	22
Sertraline Hcl	Sertraline Hcl	112	34
Bupropion Xl	Bupropion Hcl	109	26
Alprazolam	Alprazolam	106	19
Zolpidem Tartrate	Zolpidem Tartrate	105	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	103	24
Clonazepam	Clonazepam	98	20
Simvastatin	Simvastatin	92	24
Furosemide	Furosemide	84	21
Meloxicam	Meloxicam	78	24
Alendronate Sodium	Alendronate Sodium	75	21
Duloxetine Hcl	Duloxetine Hcl	74	21
Escitalopram Oxalate	Escitalopram Oxalate	74	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	suppressed
Lorazepam	Lorazepam	65	21
Pantoprazole Sodium	Pantoprazole Sodium	65	20
Montelukast Sodium	Montelukast Sodium	58	19
Metoprolol Tartrate	Metoprolol Tartrate	57	16
Synthroid	Levothyroxine Sodium	53	17
Jardiance	Empagliflozin	49	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	49	14
Oxycodone Hcl	Oxycodone Hcl	48	11
Potassium Chloride	Potassium Chloride	47	12
Albuterol Sulfate Hfa	Albuterol Sulfate	46	25
Allopurinol	Allopurinol	45	12
Pravastatin Sodium	Pravastatin Sodium	45	11
Estradiol	Estradiol	44	13
Ozempic	Semaglutide	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	13
Warfarin Sodium	Warfarin Sodium	44	12
Mirtazapine	Mirtazapine	43	13
Baclofen	Baclofen	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	12
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Metoprolol Succinate	Metoprolol Succinate	38	14
Metformin Hcl Er	Metformin Hcl	36	12
Carvedilol	Carvedilol	35	11
Pregabalin	Pregabalin	35	12
Prednisone	Prednisone	34	11
Trulicity	Dulaglutide	34	suppressed
Fluconazole	Fluconazole	33	15
Citalopram Hbr	Citalopram Hydrobromide	32	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Spironolactone	Spironolactone	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	11
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Ertapenem	Ertapenem Sodium	24	suppressed
Sodium Chloride	0.9 % Sodium Chloride	24	suppressed
Azithromycin	Azithromycin	23	16
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Famotidine	Famotidine	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Lactated Ringers	Ringer's Solution,lactated	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Tradjenta	Linagliptin	21	suppressed
Diazepam	Diazepam	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	11
Donepezil Hcl	Donepezil Hcl	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Modafinil	Modafinil	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	12
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Atenolol	Atenolol	17	suppressed
Cephalexin	Cephalexin	17	13
Glipizide Er	Glipizide	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Valsartan	Valsartan	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Nystatin	Nystatin	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Methylprednisolone	Methylprednisolone	13	12
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Tri-Lo-Estarylla	Norgestimate-Ethinyl Estradiol	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Glipizide	Glipizide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error